IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Autologous Umbilical Cord Blood Transfusion for Preterm Neonates
The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2013 by Sahar M.A. Hassanein, MD, Ain Shams University.
Recruitment status was: Recruiting
Recruitment status was: Recruiting
Sponsor:
Sahar M.A. Hassanein, MD
Information provided by (Responsible Party):
Sahar M.A. Hassanein, MD, Ain Shams University
ClinicalTrials.gov Identifier:
NCT01121328
First received: May 3, 2010
Last updated: April 25, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This is a pilot study to test feasibility of collection, preparation and infusion of a baby's own (autologous) umbilical cord blood in the first 14 days after birth if the baby is born premature <35 weeks of gestation.
| Condition | Intervention | Phase |
|---|---|---|
| Prematurity Respiratory Distress Syndrome Anemia of Prematurity Intraventricular Hemorrhage | Biological: Autologous cord blood transfusion for preterm neonates Biological: Autologous cord blood transfusion | Phase 1 |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Supportive Care |
| Official Title: | Autologous Umbilical Cord Blood Transfusion for Preterm and Low Birth Weight Neonates: A Pilot Feasibility Study |
Resource links provided by NLM:
MedlinePlus related topics:
Blood Transfusion and Donation
Genetic and Rare Diseases Information Center resources:
Respiratory Distress Syndrome, Infant
Acute Respiratory Distress Syndrome
U.S. FDA Resources
Further study details as provided by Sahar M.A. Hassanein, MD, Ain Shams University:
Primary Outcome Measures:
- Duration of mechanical ventilation [ Time Frame: 30 days ]-No need for mechanical ventilation.
Secondary Outcome Measures:
- Survival [ Time Frame: 18 months ]
- Survival until 12 months of age.
- Improved physical growth and weight gain.
- Neurodevelopmental outcome at 6, 12 and 18 months of age.
| Estimated Enrollment: | 60 |
| Study Start Date: | July 2011 |
| Estimated Study Completion Date: | September 2014 |
| Estimated Primary Completion Date: | March 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Autologous cord blood transfusion
Collected cord blood at birth will be transfused for the preterm neonate
|
Biological: Autologous cord blood transfusion for preterm neonates
Cord blood collection after delivery of the baby. Preservation of blood in blood bank. Transfusion of blood within the first 14 postnatal days to maintain Hb level above 10gm%.
Other Name: Transfusion blood bag collection.
Biological: Autologous cord blood transfusion
After delivery of the baby and before placental delivery in vaginal delivery. After delivery of the baby the placental will be taken out in cesarean section. sterilization of the umbilical cord will be done. Puncture of the umbilical cord vein with the needle of blood transfusion bag will be done. Blood will be kept in the blood bank. Blood grouping, haematocrit and CBC will be done for the cord blood.Maternal sample will be analysed simultaneously. Mononuclear layer will be separated within 6 hours and transfused to the preterm neonate immediately. RBCs will be separated and kept till need (Hb less than 10 gm%). Other Name: Cord blood transfusion for preterm neonates
|
Detailed Description:
In Egypt, 12-15.8% of live neonates are low birth weight and it is estimated that about one third of such infants are preterm [1] (UNICEF, 2001). In a study that Campbell et al. (2004) conducted in Egypt, the neonatal mortality rate was estimated to be 25 per 1000 live births. prematurity was considered the main cause of neonatal deaths (39%), followed by asphyxia (18%), infection (7%), especially in the late neonatal period, and congenital malformations (6%). A substantial proportion (29%) could not be classified [2]. In developing countries, prematurity was the main cause of early neonatal deaths (62%)[3] Autologous cord blood transfusion will be safe, and cheap. The preterm neonates need transfusion of whole blood or any of its components at a time during NICU admission.
Eligibility| Ages Eligible for Study: | up to 30 Days (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Preterm neonates less than 34 weeks of gestation.
- Low birth weight less than 1500 grams
Exclusion Criteria:
- Congenital malformations.
- Suspected inborn error of metabolism.
- Suspected inherited neurologic disease.
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01121328
Please refer to this study by its ClinicalTrials.gov identifier: NCT01121328
Contacts
| Contact: Dr. Sahar MA Hassanein, MD | +20123183943 | saharhassanein@med.asu.edu.eg |
Locations
| Egypt | |
| Children's Hospital, Faculty of Medicine, Ain Shams University | Recruiting |
| Cairo, Egypt, 11381 | |
| Contact: Mohsen Elalfy, MD +201000864343 | |
| Principal Investigator: Prof. Dr. Sahar MA Hassanein, MD | |
Sponsors and Collaborators
Sahar M.A. Hassanein, MD
Investigators
| Principal Investigator: | Prof. Sahar MA Hassanein, MD | Children's Hospital, Faculty of Medicine, Ain Shams University |
More Information
| Responsible Party: | Sahar M.A. Hassanein, MD, Professor of Pediatrics, Children's Hospital, Faculty of Medicine, Ain Shams University |
| ClinicalTrials.gov Identifier: | NCT01121328 History of Changes |
| Other Study ID Numbers: |
IRB#1 |
| Study First Received: | May 3, 2010 |
| Last Updated: | April 25, 2013 |
Keywords provided by Sahar M.A. Hassanein, MD, Ain Shams University:
|
Preterm neonates. Autologous cord blood transfusion. |
Additional relevant MeSH terms:
|
Hemorrhage Respiratory Distress Syndrome, Newborn Respiratory Distress Syndrome, Adult Premature Birth Cerebral Hemorrhage Pathologic Processes Lung Diseases Respiratory Tract Diseases Respiration Disorders Infant, Premature, Diseases Infant, Newborn, Diseases |
Obstetric Labor, Premature Obstetric Labor Complications Pregnancy Complications Intracranial Hemorrhages Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases Nervous System Diseases Vascular Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on July 27, 2017